Package 51662-1269-1

Brand: verapamil hci

Generic: verapamil hci
NDC Package

Package Facts

Identity

Package NDC 51662-1269-1
Digits Only 5166212691
Product NDC 51662-1269
Description

2 mL in 1 VIAL, SINGLE-DOSE (51662-1269-1)

Marketing

Marketing Status
Marketed Since 2018-09-17
Brand verapamil hci
Generic verapamil hci
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "1057fcb1-8b11-3a9a-e063-6394a90a7ff1", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["1665057"], "spl_set_id": ["76112f5f-ce5d-ec60-e053-2a91aa0aae4e"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "2 mL in 1 VIAL, SINGLE-DOSE (51662-1269-1)", "package_ndc": "51662-1269-1", "marketing_start_date": "20180917"}, {"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1269-2)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "51662-1269-2", "marketing_start_date": "20210122"}, {"sample": false, "description": "25 POUCH in 1 CASE (51662-1269-3)  / 1 VIAL, SINGLE-DOSE in 1 POUCH / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "51662-1269-3", "marketing_start_date": "20210122"}], "brand_name": "VERAPAMIL HCI", "product_id": "51662-1269_1057fcb1-8b11-3a9a-e063-6394a90a7ff1", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51662-1269", "generic_name": "VERAPAMIL HCI", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HCI", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA070737", "marketing_category": "ANDA", "marketing_start_date": "20180917", "listing_expiration_date": "20261231"}